Table 1

Results of meta-analysis of ARC

Subgroup		N	n	ARC (%)	95% CI	I² (%)	P value	Figure
Total		46	8828	93.13	90.62 to 95.00	92.8	<0.0001
Location	Western region	12	1379	92.80	88.14 to 95.72	82.6	<0.0001
	Central region	12	1950	87.32	81.93 to 91.28	85.8	<0.0001
	Eastern region	22	5499	95.78	92.25 to 97.74	95.7	<0.0001
Rank	Secondary hospital	14	1450	93.97	89.43 to 96.64	84.1	<0.0001
Rank	Tertiary hospital	32	7378	92.74	89.46 to 95.06	94.3	<0.0001
Risk	Non-resistant	36	7220	92.63	89.63 to 94.81	93.5	<0.0001
Risk	Resistant	10	1608	94.32	91.01 to 96.45	59.6	0.0081
Age	A	43	8288	92.79	90.07 to 94.81	93.0	<0.0001
Age	C	4	540	95.91	91.46 to 98.09	44.9	0.1420
Phase	Phase I	12	3219	89.23	84.93 to 92.42	84.5	<0.0001
Phase	Phase II	34	5609	94.63	91.60 to 96.60	93.9	<0.0001

A, adults and children; ARC, acceptance rate of consultation; C, children; N, number of studies; n, number of consultations; non-resistant, non-resistant bacteria infection; resistant, resistant bacteria infection; phase I, study time before 2011; phase II, study time after 2011. I² and p value, results of heterogeneity test.